Search research articles
Contact Us
Filters
Showing results (161-170 of 286) with videos related to
Page
of 29
Sort By:
Neuro-Oncology
|
March 22, 2025
Diffusion and contrast-enhancement MRI phenotypes associated with immune checkpoint inhibitor exposure and with immune cell infiltration in brain metastases
Francesco Sanvito, Gianluca Nocera, Zexi Wang, et al.
Radiology Case Reports
|
March 2, 2026
A multifocal IDH-mutant glioma with differential response to IDH inhibition: Role of quantitative neuroimaging
Omar Ibrahim, Nicholas S Cho, Viên Lam Le, et al.
Journal of Neuro-Oncology
|
April 22, 2018
<sup>18</sup>F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study
Chirag B Patel, Elisa Fazzari, Ararat Chakhoyan, et al.
Neuro-Oncology Advances
|
August 9, 2023
Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma
Sonoko Oshima, Akifumi Hagiwara, Catalina Raymond, et al.
The Journal of Urology
|
February 26, 2015
Brain White Matter Abnormalities in Female Interstitial Cystitis/Bladder Pain Syndrome: A MAPP Network Neuroimaging Study
Melissa A Farmer, Lejian Huang, Katherine Martucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2020
First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma
Patrick Y Wen, Timothy F Cloughesy, Alan G Olivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2020
Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma
Benjamin M Ellingson, Jingwen Yao, Catalina Raymond, et al.
Neuro-Oncology Advances
|
May 8, 2023
A single-institution retrospective analysis of pathologically determined malignant transformation in <i>IDH</i> mutant glioma patients
Vicki Liu, Ethan A Wetzel, Blaine S C Eldred, et al.
Journal of Neuro-Oncology
|
February 27, 2019
pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma
Jingwen Yao, Caleb Hock Pang Tan, Jacob Schlossman, et al.
Neuro-Oncology
|
May 29, 2024
Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors
Nicholas S Cho, Viên Lam Le, Francesco Sanvito, et al.
Page
of 29
Search research articles
Search
Showing results (161-170 of 286) with videos related to
Sort By:
Page
of 29
Neuro-Oncology
|
March 22, 2025
Diffusion and contrast-enhancement MRI phenotypes associated with immune checkpoint inhibitor exposure and with immune cell infiltration in brain metastases
Francesco Sanvito, Gianluca Nocera, Zexi Wang, et al.
Radiology Case Reports
|
March 2, 2026
A multifocal IDH-mutant glioma with differential response to IDH inhibition: Role of quantitative neuroimaging
Omar Ibrahim, Nicholas S Cho, Viên Lam Le, et al.
Journal of Neuro-Oncology
|
April 22, 2018
<sup>18</sup>F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study
Chirag B Patel, Elisa Fazzari, Ararat Chakhoyan, et al.
Neuro-Oncology Advances
|
August 9, 2023
Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma
Sonoko Oshima, Akifumi Hagiwara, Catalina Raymond, et al.
The Journal of Urology
|
February 26, 2015
Brain White Matter Abnormalities in Female Interstitial Cystitis/Bladder Pain Syndrome: A MAPP Network Neuroimaging Study
Melissa A Farmer, Lejian Huang, Katherine Martucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2020
First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma
Patrick Y Wen, Timothy F Cloughesy, Alan G Olivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2020
Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma
Benjamin M Ellingson, Jingwen Yao, Catalina Raymond, et al.
Neuro-Oncology Advances
|
May 8, 2023
A single-institution retrospective analysis of pathologically determined malignant transformation in <i>IDH</i> mutant glioma patients
Vicki Liu, Ethan A Wetzel, Blaine S C Eldred, et al.
Journal of Neuro-Oncology
|
February 27, 2019
pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma
Jingwen Yao, Caleb Hock Pang Tan, Jacob Schlossman, et al.
Neuro-Oncology
|
May 29, 2024
Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors
Nicholas S Cho, Viên Lam Le, Francesco Sanvito, et al.
Page
of 29